Integrating Artificial Intelligence into metabolomics for predicting diseases

Area of Science:

• Biomedical science
• Computational biology
• Metabolomics

Background:

• Early disease diagnosis is crucial for effective treatment and better patient outcomes.
• Metabolomics enables the detection of subtle metabolic shifts indicative of disease onset before clinical manifestation.
• It offers insights into disease progression and underlying mechanisms, aiding biomarker discovery for various conditions.

Purpose of the Study:

• To provide an overview of integrating Artificial Intelligence (AI) into metabolomics.
• To address the analytical challenges posed by high-dimensional metabolomics data.
• To explore AI-driven strategies for predictive and personalized medicine using metabolomics.

Main Methods:

• Review of Artificial Intelligence (AI) applications in metabolomics workflows.
• Discussion of machine learning (ML) and deep learning (DL) approaches for data analysis.
• Examination of computational strategies for managing complex, high-dimensional metabolic data.

Main Results:

• AI, ML, and DL methods are integrated into metabolomics to overcome data complexity and heterogeneity.
• These computational strategies facilitate the extraction of meaningful insights from large-scale metabolic profiling.
• Case studies and methodological advancements illustrate the utility of AI in disease prediction.

Conclusions:

• AI significantly enhances the predictive power of metabolomics for early disease detection.
• Advanced computational approaches are essential for realizing the potential of metabolomics in personalized medicine.
• The integration of AI into metabolomics workflows represents a significant step forward in disease prediction and management.